H. B. Fuller (NYSE:FUL) Releases Earnings Results, Beats Estimates By $0.04 EPS

H. B. Fuller (NYSE:FUL) released its earnings results on Wednesday. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.04, Zacks reports. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%. H. B. Fuller updated its FY 2026 guidance to 4.600-4.900 EPS.

H. B. Fuller Stock Performance

Shares of NYSE FUL traded up $1.36 during midday trading on Wednesday, hitting $64.48. The company’s stock had a trading volume of 1,121,926 shares, compared to its average volume of 594,637. The firm has a market capitalization of $3.51 billion, a price-to-earnings ratio of 21.28, a P/E/G ratio of 0.84 and a beta of 0.96. The company has a current ratio of 1.92, a quick ratio of 1.15 and a debt-to-equity ratio of 1.01. The stock has a fifty day moving average price of $61.62 and a 200 day moving average price of $61.21. H. B. Fuller has a one year low of $48.71 and a one year high of $68.63.

H. B. Fuller Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were paid a $0.245 dividend. The ex-dividend date was Thursday, April 30th. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.23. This represents a $0.98 annualized dividend and a dividend yield of 1.5%. H. B. Fuller’s dividend payout ratio is 32.34%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. UBS Group raised their target price on H. B. Fuller from $63.00 to $71.00 and gave the company a “neutral” rating in a research report on Wednesday, June 17th. Vertical Research upgraded shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, March 27th. Citigroup boosted their target price on shares of H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, March 30th. Wall Street Zen raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. Finally, Royal Bank Of Canada set a $58.00 price target on shares of H. B. Fuller in a report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $66.40.

Insider Buying and Selling

In other H. B. Fuller news, CEO Celeste Beeks Mastin acquired 5,170 shares of H. B. Fuller stock in a transaction that occurred on Tuesday, April 7th. The stock was acquired at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the purchase, the chief executive officer owned 8,670 shares of the company’s stock, valued at approximately $494,883.60. This represents a 147.71% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.83% of the company’s stock.

Institutional Trading of H. B. Fuller

A number of hedge funds and other institutional investors have recently made changes to their positions in FUL. Strs Ohio bought a new position in H. B. Fuller in the 1st quarter worth about $101,000. EverSource Wealth Advisors LLC lifted its holdings in shares of H. B. Fuller by 129.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after buying an additional 688 shares in the last quarter. Baird Financial Group Inc. boosted its position in shares of H. B. Fuller by 19.6% in the second quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock valued at $452,000 after acquiring an additional 1,232 shares during the period. Marshall Wace LLP boosted its position in shares of H. B. Fuller by 382.1% in the second quarter. Marshall Wace LLP now owns 20,370 shares of the specialty chemicals company’s stock valued at $1,225,000 after acquiring an additional 16,145 shares during the period. Finally, Cerity Partners LLC grew its stake in H. B. Fuller by 2.3% during the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock valued at $692,000 after acquiring an additional 261 shares in the last quarter. 95.93% of the stock is currently owned by institutional investors.

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.